Precision BioSciences Inc (NASDAQ:DTIL)
| 10.68 Delayed Data As of Jan 17 |  -0.41 / -3.70%Today’s Change | 6.24 Today|||52-Week Range 23.67 | -23.11% Year-to-Date |
Latest DTIL News | Press Releases
| These Gene-Editing Pioneers Are Making Bold Bets in Agriculture Jan 18 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 11.09 |
| Today’s open | 11.19 |
| Day’s range | 10.51 - 11.46 |
| Volume | 801,417 |
| Average volume (3 months) | 885,131 |
| Market cap | $542.4M |
Data as of 4:00pm ET, 01/17/2020
Growth & Valuation
| Earnings growth (last year) | -118.18% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +67.84% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 13.42 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AGENAgenus Inc | +0.09 | +2.34% |
| MGTAMagenta Therapeutics... | -0.26 | -1.81% |
| AUTLAutolus Therapeutics... | -0.30 | -2.33% |
| PRTAProthena Corporation... | -1.12 | -7.28% |
Data as of 4:00pm ET, 01/17/2020
Financials
| Next reporting date | February 26, 2020 |
| EPS forecast (this quarter) | -$0.47 |
| Annual revenue (last year) | $10.9M |
| Annual profit (last year) | -$46.0M |
| Net profit margin | -423.02% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Durham, North Carolina |
Forecasts
